Mechanisms underlying myometrial quiescence during pregnancy

Fetal and Maternal Medicine Review

Volumn 14, Issue 3, 2003, Pages 209-237

  Carvajal, Jorge A ^a   Weiner, Carl P ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CYCLIC AMP; CYCLIC GMP; ION CHANNEL; NATRIURETIC FACTOR; NEUROPEPTIDE; NITRIC OXIDE; POTASSIUM CHANNEL; PROGESTERONE;

GENE CONTROL; MYOMETRIUM; PREGNANCY; REVIEW; SECOND MESSENGER; SMOOTH MUSCLE RELAXATION; UTERUS CONTRACTILITY;

EID: 0242667021     PISSN: 09655395     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0965539503001098     Document Type: Review

References (176)

1. Cunningham FG, MacDonald PC, Gant NF, Leveno KJ, Gilstrap III LC, Hankins GDV et al. Parturition In: Cunningham FG, MacDonald PC, Gant NF, et al., eds. Williams Obstetrics. 20th ed. Stamford, Connecticut: Appleton & Lange, 1997.
2. Norwitz ER, Robinson JN, Challis JR. The control of labor. N Engl J Med 1999; 341: 660-66.
3. Lopez Bernal A, Rivera J, Europe-Finner GN, Phaneuf S, Asboth G. Parturition: activation of stimulatory pathways or loss of uterine quiescence? Adv Exp Med Biol 1995; 395: 435-51.
4. Creasy R. Preterm labor and delivery. In: Creasy R, Resnik R, eds. Maternal-fetal Medicine: Principles and Practice. Philadelphia: WB Sauders, 1994; 494-95.
5. Buhimschi IA, Buhimschi CS, Weiner CP. Protective effect of N-acetylcysteine against fetal death and preterm labor induced by maternal inflammation. Am J Obstet Gynecol 2003; 188: 203-208.
6. Bobby PD, Divon MY. Fetal testing in postdates. Curr Opin Obstet Gynecol 1997; 9: 79-82.
7. Olson DM, Mijovic JE, Sadowsky DW. Control of human parturition. Semin Perinatol 1995; 19: 52-63.
8. Carvajal JA, Buhimschi IA, Thompson LP, Aguan K, Weiner CP. Chorion releases a factor that inhibits oxytocin-stimulated myometrial contractility in the pregnant guinea pig. Hum Reprod 2001; 16: 638-43.
9. Collins PL, Idriss E, Moore JJ. Human fetal membranes inhibit spontaneous uterine contractions. J Clin Endocrinol Metab 1993; 77: 1479-84.
10. Bryant-Greenwood G, Greenwood F. The human fetal membranes and decidua as a model for paracrine interactions. In: Mc Neilis D, Challis J, MacDonald P, Nathanielsz PW, Roberts JM eds. The onset of labor: cellular and integrative mechanisms. Ithaca (NY): Perinatology Press, 1998; 253-73.
11. Lincoln TM, Cornwell TL. Intracellular cyclic GMP receptor proteins. FASEB J 1993; 7: 328-38.
12. Vaandrager AB, de Jonge HR. Signalling by cGMP-dependent protein kinases. Mol Cell Biochem 1996; 157: 23-30.
13. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-42.
14. Morita T, Perrella MA, Lee ME, Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 1995; 92: 1475-79.
15. Maack T. Receptors of atrial natriuretic factor. Annu Rev Physiol 1992; 54: 11-27.
16. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725-48.
17. Leroy MJ, Pichard AL, Cabrol D, Ferre F. Cyclic 3′:5′ -nucleotide phosphodiesterase in human myometrium at the end of pregnancy: partial purification and characterization of the different soluble isoenzymes. Gynecol Obstet Invest 1985; 20: 27-36.
18. Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP. Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol 2000; 184: 409-20.
19. Kannan MS, Johnson DE. Modulation of nitric oxide-dependent relaxation of pig tracheal smooth muscle by inhibitors of guanylyl cyclase and calcium activated potassium channels. Life Sci 1995; 56: 2229-238.
20. + channels in porcine tracheal smooth muscle cells. Am J Physiol 1996; 270: L338-45.
21. + currents by cGMP-dependent protein kinase in tracheal smooth muscle and Chinese hamster ovary cells. J Biol Chem 1996; 271: 19760-767.
22. Clapp LH, Gurney AM. Modulation of calcium movements by nitroprusside in isolated vascular smooth muscle cells. Pflugers Arch 1991; 418: 462-70.
23. Quignard JF, Frapier JM, Harricane MC, Albat B, Nargeot J, Richard S. Voltage-gated calcium channel currents in human coronary myocytes. Regulation by cyclic GMP and nitric oxide. J Clin Invest 1997; 99: 185-93.
24. 2+ channel availability in basilar artery smooth muscle cells. Pflugers Arch 1997; 433: 304-11.
25. 2+ pump by cyclic nucleotides in cultured vascular smooth muscle cells. J Biol Chem 1988; 263: 8058-8065.
26. 2+-ATPase by cGMP-dependent protein kinase. Proc Natl Acad Sci USA 1987; 84: 5685-689.
27. 2+ pump of smooth muscle via phosphorylation of phosphatidylinositol. Biochem J 1988; 255: 855-63.
28. 2+ pump ATPase of vascular smooth muscle via phosphorylation of a 240-kDa protein. J Biol Chem 1991; 266: 19819-825.
29. Cornwell TL, Pryzwansky KB, Wyatt TA, Lincoln TM. Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells. Mol Pharmacol 1991; 40: 923-31.
30. Raeymaekers L, Hofmann F, Casteels R. Cyclic GMP-dependent protein kinase phosphorylates phospholamban in isolated sarcoplasmic reticulum from cardiac and smooth muscle. Biochem J 1988; 252: 269-73.
31. Komalavilas P, Lincoln TM. Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic GMP-dependent protein kinase. J Biol Chem 1994; 269: 8701-8707.
32. Komalavilas P, Lincoln TM. Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta. J Biol Chem 1996; 271: 21933-938.
33. Hirata M, Kohse KP, Chang CH, Ikebe T, Murad F. Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segments and cultured bovine aortic smooth muscle cells. J Biol Chem 1990; 265: 1268-73.
34. Pfeifer A, Nurnberg B, Kamm S, Uhde M, Schultz G, Ruth P et al. Cyclic GMP-dependent protein kinase blocks pertussis toxin-sensitive hormone receptor signaling pathways in Chinese hamster ovary cells. J Biol Chem 1995; 270: 9052-9059.
35. Rapoport RM. Cyclic guanosine monophosphate inhibition of contraction may be mediated through inhibition of phosphatidylinositol hydrolysis in rat aorta. Circ Res 1986; 58: 407-10.
36. 2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase. J Biol Chem 1997; 272: 5063-5068.
37. Wu X, Somlyo AV, Somlyo AP. Cyclic GMP-dependent stimulation reverses G-protein-coupled inhibition of smooth muscle myosin light chain phosphate. Biochem Biophys Res Commun 1996; 220: 658-63.
38. Kumar R, Cartledge WA, Lincoln TM, Pandey KN. Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase. Hypertension 1997; 29: 414-21.
39. Bergh CM, Brophy CM, Dransfield DT, Lincoln T, Goldenring JR, Rasmussen H. Impaired cyclic nucleotide-dependent vasorelaxation in human umbilical artery smooth muscle. Am J Physiol 1995; 268: H202-12.
40. Beall AC, Kato K, Goldenring JR, Rasmussen H, Brophy CM. Cyclic nucleotide-dependent vasorelaxation is associated with the phosphorylation of a small heat shock-related protein. J Biol Chem 1997; 272: 11283-287.
41. Weiner CP, Knowles RG, Nelson SE, Stegink LD. Pregnancy increases guanosine 3′,5′-monophosphate in the myometrium independent of nitric oxide synthesis. Endocrinology 1994; 135: 2473-478.
42. Yallampalli C, Izumi H, Byam-Smith M, Garfield RE. An L-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am J Obstet Gynecol 1994; 170: 175-85.
43. Aggelidou E, Hillhouse EW, Grammatopoulos DK. Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells. Proc Natl Acad Sci USA 2002; 99: 3300-305.
44. Telfer JF, Itoh H, Thomson AJ, Norman JE, Nakao K, Campa JS et al. Activity and expression of soluble and particulate guanylate cyclases in myometrium from nonpregnant and pregnant women: down-regulation of soluble guanylate cyclase at term. J Clin Endocrinol Metab 2001; 86: 5934-943.
45. 2+]i, myosin light chain phosphorylation, and contraction in human myometrium. Am J Physiol 1991; 260: C861-67.
46. Word RA, Cornwell TL. Regulation of cGMP-induced relaxation and cGMP-dependent protein kinase in rat myometrium during pregnancy. Am J Physiol 1998; 274: C748-56.
47. Hennan JK, Diamond J. Evidence that spontaneous contractile activity in the rat myometrium is not inhibited by NO-mediated increases in tissue levels of cyclic GMP. Br J Pharmacol 1998; 123: 959-67.
48. Syal AS, Vedernikov YP, Chwalisz K, Saade GR, Garfield RE. Both soluble guanylate cyclase and particulate guanylate cyclase regulate myometrial contractility. Am J Obstet Gynecol 1998; 179: 111-66.
49. Cornwell TL, Li J, Sellak H, Miller RT, Word RA. Reorganization of myofilament proteins and decreased cGMP-dependent protein kinase in the human uterus during pregnancy. J Clin Endocrinol Metab 2001; 86: 3981-988.
50. +channel opening. J Soc Gynecol Invest 2002; 9: 311A.
51. Kim HJ, Weiner CP. The obligatory role of the amniotic membranes in the synthesis of myometrial cGMP during pregnancy and its inhibition by a factor in maternal plasma. J Soc Gynecol Invest 1996; 3: 347A.
52. San Martin-Klark O, Weiner C. Pregnancy decreases nitric oxide (NO) stimulated while increasing atriopeptin stimulated guanylaye cyclase activity (GCA) in guinea pig myometrium. J Soc Gynecol Invest 1995; 2: 253.
53. Tans L, Buhimschi IA, Thompson LP, Aguan K, Weiner CP. Human chorion increases guinea pig myometrial cGMP content. J Soc Gynecol Invest 1998; 5: 183A.
54. Buhimschi IA, Carvajal JA, Thompson LP, Weiner CP. The origin of uterine cGMP during pregnancy. J Soc Gynecol Invest 2001; 8: 260A.
55. Buhimschi IA, Carvajal JA, Weiner CP. Gestational regulation of cGMP at the feto-maternal interface. J Soc Gynecol Invest 2002; 9: 197A.
56. Buhimschi I, Yallampalli C, Dong YL, Garfield RE. Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy. Am J Obstet Gynecol 1995; 172: 1577-84.
57. Natuzzi ES, Ursell PC, Harrison M, Buscher C, Riemer RK. Nitric oxide synthase activity in the pregnant uterus decreases at parturition. Biochem Biophys Res Commun 1993; 194: 1-8.
58. Gangula PR, Dong YL, Yallampalli C. Rat myometrial smooth muscle cells express endothelial nitric oxide synthase. Hum Reprod 1997; 12: 561-68.
59. Sladek SM, Regenstein AC, Lykins D, Roberts JM. Nitric oxide synthase activity in pregnant rabbit uterus decreases on the last day of pregnancy. Am J Obstet Gynecol 1993; 169: 1285-91.
60. Bansal RK, Goldsmith PC, He Y, Zaloudek CJ, Ecker JL, Riemer RK. A decline in myometrial nitric oxide synthase expression is associated with labor and delivery. J Clin Invest 1997; 99: 2502-508.
61. Dennes WJ, Slater DM, Poston L, Bennett PR. Myometrial nitric oxide synthase messenger ribonucleic acid expression does not change throughout gestation or with the onset of labor. Am J Obstet Gynecol 1999; 180: 387-92.
62. Bartlett SR, Bennett PR, Campa JS, Dennes WJ, Slater DM, Mann GE et al. Expression of nitric oxide synthase isoforms in pregnant human myometrium. J Physiol 1999; 521: 705-16.
63. Norman JE, Thompson AJ, Telfer JF, Young A, Greer IA, Cameron IT. Myometrial constitutive nitric oxide synthase expression is increased during human pregnancy. Mol Hum Reprod 1999; 5: 175-81.
64. Yallampalli C, Byam-Smith M, Nelson SO, Garfield RE. Steroid hormones modulate the production of nitric oxide and cGMP in the rat uterus. Endocrinology 1994; 134: 1971-74.
65. Kuehl FA, Jr., Ham EA, Zanetti ME, Sanford CH, Nicol SE, Goldberg ND. Estrogen-related increases in uterine guanosine 3′:5′-cyclic momophosphate levels. Proc Natl Acad Sci USA 1974; 71: 1866-70.
66. Beatty CH, Bocek RM, Herrington PT, Young MK, Brenner RM. Estradiol-17 beta and progesterone: effects on guanylate cyclase activity in the myometrium of macaques. Proc Soc Exp Biol Med 1980; 164: 292-98.
67. Vesely DL, Hill DE. Estrogens and progesterone increase fetal and maternal guanylate cyclase activity. Endocrinology 1980; 107: 2104-109.
68. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994; 91: 5212-16.
69. Buhimschi IA, San Martin-Clark O, Aguan K, Thompson LP, Weiner CP. Differential alterations in responsiveness in particulate and soluble guanylate cyclases in pregnant guinea pig myometrium. Am J Obstet Gynecol 2000; 183: 1512-19.
70. Carvajal JA, Thompson LP, Weiner CP. Chorion-induced myometrial relaxation is mediated by large-conductance Ca-activated K channel opening in the guinea pig. Am J Obstet Gynecol 2003; 188: 84-91.
71. Mirabile CP, Jr., Massmann GA, Figueroa JP. Physiologic role of nitric oxide in the maintenance of uterine quiescence in nonpregnant and pregnant sheep. Am J Obstet Gynecol 2000; 183: 191-98.
72. Yallampalli C, Dong YL, Gangula PR, Fang L. Role and regulation of nitric oxide in the uterus during pregnancy and parturition. J Soc Gynecol Investi 1998; 5: 58-67.
73. Acevedo CH, Ahmed A. Hemeoxygenase-1 inhibits human myometrial contractility via carbon monoxide and is upregulated by progesterone during pregnancy. J Clin Invest 1998; 101: 949-55.
74. Barber A, Robson SC, Lyall F. Hemoxygenase and nitric oxide synthase do not maintain human uterine quiescence during pregnancy. Am J Pathol 1999; 155: 831-40.
75. Rosenzweig A, Seidman CE. Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem 1991; 60: 229-55.
76. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev 1990; 70: 665-99.
77. Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990; 168: 863-70.
78. Arimura JJ, Minamino N, Kangawa K, Matsuo H. Isolation and identification of C-type natriuretic peptide in chicken brain. Biochem Biophys Res Commun 1991; 174: 142-48.
79. Komatsu Y, Nakao K, Suga S, Ogawa Y, Mukoyama M, Arai H et al. C-type natriuretic peptide (CNP) in rats and humans. Endocrinology 1991; 129: 1104-106.
80. Ueda S, Minamino N, Aburaya M, Kangawa K, Matsukura S, Matsuo H. Distribution and characterization of immunoreactive porcine C-type natriuretic peptide. Biochem Biophys Res Commun 1991; 175: 759-67.
81. Chrisman TD, Schulz S, Potter LR, Garbers DL. Seminal plasma factors that cause large elevations in cellular cyclic GMP are C-type natriuretic peptides. J Biol Chem 1993; 268: 3698-703.
82. Stingo AJ, Clavell AL, Heublein DM, Wei CM, Pittelkow MR, Burnett JC, Jr. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol 1992; 263: H1318-21.
83. Foster DC, Wedel BJ, Robinson SW, Garbers DL. Mechanisms of regulation and functions of guanylyl cyclases. Rev Physiol Biochem Pharmacol 1999; 135: 1-39.
84. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1992; 130: 229-39.
85. Graham CH, Watson JD, Blumenfeld AJ, Pang SC. Expression of atrial natriuretic peptide by third-trimester placental cytotrophoblasts in women. Biol Reprod 1996; 54: 834-40.
86. Itoh H, Sagawa N, Hasegawa M, Okagaki A, Inamori K, Ihara Y et al. Brain natriuretic peptide is present in the human amniotic fluid and is secreted from amnion cells. J Clin Endocrinol Metab 1993; 76: 907-11.
87. Dos Reis AM, Fujio N, Dam TV, Mukaddam-Daher S, Jankowski M, Tremblay J et al. Characterization and distribution of natriuretic peptide receptors in the rat uterus. Endocrinology 1995; 136: 4247-53.
88. Itoh H, Sagawa N, Hasegawa M, Nanno H, Kobayashi F, Ihara Y et al. Expression of biologically active receptors for natriuretic peptides in the human uterus during pregnancy. Biochem Biophys Res Commun 1994; 203: 602-607.
89. Carvajal JA, Aguan K, Thompson LP, Buhimschi IA, Weiner CP. Natriuretic peptide-induced relaxation of myometrium from the pregnant guinea pig is not mediated by guanylate cyclase activation. J Pharmacol Exp Ther 2001; 297: 181-88.
90. Yoshimura T, Yoshimura M, Yasue H, Ito M, Okamura H, Mukoyama M et al. Plasma concentration of atrial natriuretic peptide and brain natriuretic peptide during normal human pregnancy and the postpartum period. J Endocrinol 1994; 140: 393-97.
91. Fleming SM, O'Byrne L, Grimes H, Daly KM, Morrison JJ. Amino-terminal pro-brain natriuretic peptide in normal and hypertensive pregnancy. Hypertens Pregnancy 2001; 20: 169-75.
92. Okuno S, Hamada H, Yasuoka M, Watanabe H, Fujiki Y, Yamada N et al. Brain natriuretic peptide (BNP) and cyclic guanosine monophosphate (cGMP) levels in normal pregnancy and preeclampsia. J Obstet Gynaecol Res 1999; 25: 407-10.
93. Kaaja RJ, Moore MP, Yandle TG, Ylikorkala O, Frampton CM, Nicholls MG. Blood pressure and vasoactive hormones in mild preeclampsia and normal pregnancy. Hypertens Pregnancy 1999; 18: 173-87.
94. Itoh H, Sagawa N, Nanno H, Mori T, Mukoyama M, Itoh H et al. Impaired guanosine 3′,5′-cyclic phosphate production in severe pregnancy-induced hypertension with high plasma levels of atrial and brain natriuretic peptides. Endocr J 1997; 44: 389-93.
95. Furuhashi N, Kimura H, Nagae H, Yajima A, Kimura C, Saito T. Brain natriuretic peptide and atrial natriuretic peptide levels in normal pregnancy and preeclampsia. Gynecol Obstet Invest 1994; 38: 73-77.
96. Albert PR, Robillard L. G protein specificity: traffic direction required. Cell Signal 2002; 14: 407-18.
97. Mirshahi T, Mittal V, Zhang H, Linder ME, Logothetis DE. Distinct sites on G protein beta gamma subunits regulate different effector functions. J Biol Chem 2002; 277: 36345-350.
98. Price SA, Pochun I, Phaneuf S, Lopez Bernal A. Adenylyl cyclase isoforms in pregnant and nonpregnant human myometrium. J Endocrinol 2000; 164: 21-30.
99. Berridge MJ, Bourne H, Hafen E, Lefkowitz RJ, Nelson ME, Simon MI et al. Cell signaling. In: Albert B, Bray D, Lewis J, Raff M, Roberts K, Watson JD eds. Molecular Biology of The Cell. New York: Garland Publishing Inc., 1994; 734-59.
100. Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000; 21: 514-50.
101. Word RA. Myosin phosphorylation and the control of myometrial contraction/relaxation. Semin Perinatol 1995; 19: 3-14.
102. Sanborn BM, Qian A, Ku CY, Wen Y, Anwer K, Monga M et al. Mechanisms regulating oxytocin receptor coupling to phospholipase C in rat and human myometrium. Adv Exp Med Biol 1995; 395: 469-79.
103. Sanborn BM, Yue C, Wang W, Dodge KL. G protein signalling pathways in myometrium: affecting the balance between contraction and relaxation. Rev Reprod 1998; 3: 196-205.
104. 2+) channels (Ca(V)1.2a,b) by protein kinases. Am J Physiol Cell Physiol 2001; 281: C1743-56.
105. Meera P, Anwer K, Monga M, Oberti C, Stefani E, Toro L et al. Relaxin stimulates myometrial calcium-activated potassium channel activity via protein kinase A. Am J Physiol 1995; 269: C312-17.
106. Zhou XB, Arntz C, Kamm S, Motejlek K, Sausbier U, Wang GX et al. A molecular switch for specific stimulation of the BKCa channel by cGMP and cAMP kinase. J Biol Chem 2001; 276: 43239-45.
107. Tonkowicz PA, Poisner AM. Evidence for a role for adenosine 3′,5′-monophosphate in progesterone secretion by human chorion. Endocrinology 1985; 116: 646-50.
108. Bailey J, Sparey C, Phillips RJ, Gilmore K, Robson SC, Dunlop W et al. Expression of the cyclic AMP-dependent transcription factors, CREB, CREM and ATF2, in the human myometrium during pregnancy and labour. Mol Hum Reprod 2000; 6: 648-60.
109. Price SA, Bernal AL. Uterine quiescence: the role of cyclic AMP. Exp Physiol 2001; 86: 265-72.
110. Europe-Finner GN, Phaneuf S, Tolkovsky AM, Watson SP, Lopez Bernal A. Down-regulation of G alpha s in human myometrium in term and preterm labor: a mechanism for parturition. J Clin Endocrinol Metab 1994; 79: 1835-39.
111. Lindeman KS, Forrester DJ, Hirshman CA, Emala CW. Myometrial adenylyl cyclase protein decreases on the last day of pregnancy in the rat. Biol Reprod 2000; 62: 1422-26.
112. Brodt-Eppley J, Myatt L. Prostaglandin receptors in lower segment myometrium during gestation and labor. Obstet Gynecol 1999; 93: 89-93.
113. Casey ML, Smith J, Alsabrook G, MacDonald PC. Activation of adenylyl cyclase in human myometrial smooth muscle cells by neuropeptides. J Chn Endocrinol Metab 1997; 82: 3087-92.
114. Dong YL, Fang L, Kondapaka S, Gangula PR, Wimalawansa SJ, Yallampalli C. Involvement of calcitonin gene-related peptide in the modulation of human myometrial contractility during pregnancy. J Clin Invest 1999; 104: 559-65.
115. Liu YL, Nwosu UC, Rice PJ. Relaxation of isolated human myometrial muscle by beta2-adrenergic receptors but not beta1-adrenergic receptors. Am J Obstet Gynecol 1998; 179: 895-98.
116. Engstrom T, Bratholm P, Vilhardt H, Christensen NJ. Effect of pregnancy on rat myometrial beta 2-adrenoceptor mRNA and isoproterenol-induced relaxation of isolated uterine strips. J Endocrinol 1997; 153: 393-99.
117. Litime MH, Pointis G, Breuiller M, Cabrol D, Ferre F. Disappearance of beta-adrenergic response of human myometrial adenylate cyclase at the end of pregnancy. J Clin Endocrinol Metab 1989; 69: 1-6.
118. Zuo J, Lei ZM, Rao CV. Human myometrial chorionic gonadotropin/luteinizing hormone receptors in preterm and term deliveries. J Clin Endocrinol Metab 1994; 79: 907-11.
119. Arkinstall SJ, Jones CT. Influence of pregnancy on G-protein coupling to adenylate cyclase activation in guinea-pig myometrium. J Endocrinol 1990; 127: 15-21.
120. Europe-Finner GN, Phaneuf S, Watson SP, Lopez Bernal A. Identification and expression of G-proteins in human myometrium: up-regulation of G alpha s in pregnancy. Endocrinology 1993; 132: 2484-90.
121. Europe-Finner GN, Phaneuf S, Cartwright E, Mardon HJ, Lopez Bernal A. Expression of human myometrial G alpha s messenger ribonucleic acid transcript during pregnancy and labour: involvement of alternative splicing pathways. J Mol Endocrinol 1997; 18: 15-25.
122. Gsell S, Eschenhagen T, Kaspareit G, Nose M, Scholz H, Behrens O et al. Apparent up-regulation of stimulatory G-protein alpha subunits in the pregnant human myometrium is mimicked by elevated smoothelin expression. FASEB J 2000; 14: 17-26.
123. Arkinstall SJ, Jones CT. Pregnancy suppresses G protein coupling to phosphoinositide hydrolysis in guinea pig myometrium. Am J Physiol 1990; 259: E57-65.
124. Mhaouty-Kodja S, Bouet-Alard R, Limon-Boulez I, Maltier JP, Legrand C. Molecular diversity of adenylyl cyclases in human and rat myometrium. Correlation with global adenylyl cyclase activity during mid- and term pregnancy. J Biol Chem 1997; 272: 31100-106.
125. Linton EA, Woodman JR, Asboth G, Glynn BP, Plested CP, Bernal AL. Corticotrophin releasing hormone: its potential for a role in human myometrium. Exp Physiol 2001; 86: 273-81.
126. Grammatopoulos DK, Hillhouse EW. Role of corticotropin-releasing hormone in onset of labour. Lancet 1999; 354: 1546-49.
127. Yallampalli C, Gangula PR, Kondapaka S, Fang L, Wimalawansa S. Regulation of calcitonin gene-related peptide receptors in the rat uterus during pregnancy and labor and by progesterone. Biol Reprod 1999; 61: 1023-30.
128. Downing SJ, Sherwood OD. The physiological role of relaxin in the pregnant rat. II. The influence of relaxin on uterine contractile activity. Endocrinology 1985; 116: 1206-14.
129. Porter DG, Downing SJ, Bradshaw JM. Inhibition of oxytocin-or prostaglandin F2alpha-driven myometrial activity by relaxin in the rat is oestrogen-dependent. J Endocrinol 1981; 89: 399-404.
130. Bani D, Baccari MC, Nistri S, Calamai F, Bigazzi M, Sacchi TB. Relaxin up-regulates the nitric oxide biosynthetic pathway in the mouse uterus: involvement in the inhibition of myometrial contractility. Endocrinology 1999; 140: 4434-41.
131. Wray S, Kupittayanant S, Shmygol A, Smith RD, Burdyga T. The physiological basis of uterine contractility: a short review. Exp Physiol 2001; 86: 239-46.
132. Khan RN, Matharoo-Ball B, Arulkumaran S, Ashford ML. Potassium channels in the human myometrium. Exp Physiol 2001; 86: 255-64.
133. Collins PL, Moore JJ, Lundgren DW, Choobineh E, Chang SM, Chang AS. Gestational changes in uterine L-type calcium channel function and expression in guinea pig. Biol Reprod 2000; 63: 1262-70.
134. Collins PL, Idriss E, Moore JJ. Fetal membranes inhibit prostaglandin but not oxytocin-induced uterine contractions. Am J Obstet Gynecol 1995; 172: 1216-23.
135. Collins PL, Moore JJ, Idriss E, Kulp TM. Human fetal membranes inhibit calcium L-channel activated uterine contractions. Am J Obstet Gynecol 1996; 175: 1173-179.
136. ++ channel inhibitor. Am J Obstet Gynecol 1998; 179: 989-93.
137. Carroll EM, Gianopoulos JG, Collins PL. Abnormality of calcium channel inhibitor released from fetal membranes in preterm labor. Am J Obstet Gynecol 2001; 184: 356-62.
138. Kobayashi H, Suzuki K, Sugino D, Terao T. Urinary trypsin inhibitor levels in amniotic fluid of normal human pregnancy: decreased levels observed at parturition. Am J Obstet Gynecol 1999; 180: 141-47.
139. Kanayama N, el Maradny E, Yamamoto N, Tokunaga N, Maehara K, Terao T. Urinary trypsin inhibitor: a new drug to treat preterm labor: a comparative study with ritodrine. Eur J Obstet Gynecol Reprod Biol 1996; 67: 133-38.
140. ++ influx. Am J Obstet Gynecol 1995; 173: 192-99.
141. + currents in freshly isolated myocytes of the pregnant human myometrium. J Physiol 1999; 518: 769-81.
142. + channels in human myometrium during pregnancy and labour. Proc R Soc Lond B Biol Sci 1993; 251: 9-15.
143. + channels in nonlabor and labor human uterine myocytes. Am J Physiol 1997; 273: C1721-731.
144. Khan RN, Morrison JJ, Smith SK, Ashford ML. Activation of large-conductance potassium channels in pregnant human myometrium by pinacidil. Am J Obstet Gynecol 1998; 178: 1027-34.
145. Khan RN, Smith SK, Ashford ML. Contribution of calcium-sensitive potassium channels to NS1619-induced relaxation in human pregnant myometrium. Hum Reprod 1998; 13: 208-13.
146. Perez GJ, Toro L, Erulkar SD, Stefani E. Characterization of large-conductance, calcium-activated potassium channels from human myometrium. Am J Obstet Gynecol 1993; 168: 652-60.
147. Perez G, Toro L. Differential modulation of large-conductance KCa channels by PKA in pregnant and nonpregnant myometrium. Am J Physiol 1994; 266: C1459-63.
148. Zhou XB, Wang GX, Ruth P, Huneke B, Korth M. BK(Ca) channel activation by membrane-associated cGMP kinase may contribute to uterine quiescence in pregnancy. Am J Physiol Cell Physiol 2000; 279: C1751-759.
149. Aguan K, Carvajal JA, Thompson LP, Weiner CP. Application of a functional genomics approach to identify differentially expressed genes in human myometrium during pregnancy and labour. Mol Hum Reprod 2000; 6: 1141-145.
150. Mahendroo MS, Porter A, Russell DW, Word RA. The parturition defect in steroid 5alpha-reductase type 1 knockout mice is due to impaired cervical ripening. Mol Endocrinol 1999; 13: 981-92.
151. Sladek SM, Westerhausen-Larson A, Roberts JM. Endogenous nitric oxide suppresses rat myometrial connexin 43 gap junction protein expression during pregnancy. Biol Reprod 1999; 61: 8-13.
152. Pollard AJ, Sparey C, Robson SC, Krainer AR, Europe-Finner GN. Spatio-temporal expression of the trans-acting splicing factors SF2/ASF and heterogeneous ribonuclear proteins A1/A1B in the myometrium of the pregnant human uterus: a molecular mechanism for regulating regional protein isoform expression in vivo. J Clin Endocrinol Metab 2000; 85: 1928-36.
153. Csapo AI, Pinto-Dantas CA. The effect of progesterone on the human uterus. Proc Natl Acad Sci USA 1965; 54: 1069-76.
154. Challis J. Characteristics of parturition. In: Creasy R, Resnik R eds. Maternal-fetal medicine. Philadephia: WB Saunders, 1994; 482-93.
155. Nathanielsz PW. Comparative studies on the initiation of labor. Eur J Obstet Gynecol Reprod Biol 1998; 78: 127-32.
156. Lopez Bernal A, Hansell DJ, Alexander S, Turnbull AC. Steroid conversion and prostaglandin production by chorionic and decidual cells in relation to term and preterm labour. Br J Obstet Gynaecol 1987; 94: 1052-58.
157. Rezapour M, Backstrom T, Lindblom B, Ulmsten U. Sex steroid receptors and human parturition. Obstet Gynecol 1997; 89: 918-24.
158. How H, Huang ZH, Zuo J, Lei ZM, Spinnato JA, 2nd, Rao CV. Myometrial estradiol and progesterone receptor changes in preterm and term pregnancies. Obstet Gynecol 1995; 86: 936-40.
159. Allport VC, Pieber D, Slater DM, Newton R, White JO, Bennett PR. Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the 'functional progesterone withdrawal'. Mol Hum Reprod 2001; 7: 581-86.
160. Lobaccaro-Henri C, Saintot M, Laffargue F, Zahradnik HP, Descomps B, Thaler-Dao H. Effect of the progesterone antagonist RU486 on human myometrial spontaneous contractility and PGI2 release. Prostaglandins 1992; 44: 443-55.
161. Haluska GJ, Cook MJ, Novy MJ. Inhibition and augmentation of progesterone production during pregnancy: effects on parturition in rhesus monkeys. Am J Obstet Gynecol 1997; 176: 682-91.
162. Casey ML, MacDonald PC. Transforming growth factor-beta inhibits progesterone-induced enkephalinase expression in human endometrial stromal cells. J Clin Endocrinol Metab 1996; 81: 4022-27.
163. Casey ML. Initiation of Parturition: Endocrine and Paracrine Regulation of Myometrial Function. Society Gynecological Investigation Postgraduate Course. San Diego, California, 1997.
164. Moses HL, Yang EY, Pietenpol JA. TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 1990; 63: 245-47.
165. Casey ML, Erk A, MacDonald PC. Parathyroid hormone and parathyroid hormone-related protein stimulate adenylate cyclase in human endometrial stromal cells. Ann N Y Acad Sci 1994; 734: 365-71.
166. Haluska GJ, Wells TR, Hirst JJ, Brenner RM, Sadowsky DW, Novy MJ. Progesterone receptor localization and isoforms in myometrium, decidua, and fetal membranes from rhesus macaques: evidence for functional progesterone withdrawal at parturition. J Soc Gynecol Investig 2002; 9: 125-36.
167. Hovland AR, Powell RL, Takimoto GS, Tung L, Horwitz KB. An N-terminal inhibitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors. J Biol Chem 1998; 273: 5455-60.
168. Mesiano S, Chan EC, Fitter JT, Kwek K, Yeo G, Smith R. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab 2002; 87: 2924-30.
169. Pieber D, Allport VC, Hills F, Johnson M, Bennett PR. Interactions between progesterone receptor isoforms in myometrial cells in human labour. Mol Hum Reprod 2001; 7: 875-79.
170. Mitchell B, Cruickshank B, McLean D, Challis J. Local modulation of progesterone production in human fetal membranes. J Clin Endocrinol Metab 1982; 55: 1237-39.
171. Powell WA, Mitchell BF, Challis JR. Effects of steroids on progesterone output by explants of human chorion. Gynecol Obstet Invest 1986; 22: 64-72.
172. Hobkirk R, Glasier MA, Wong M. The effect of chorion-uterine interaction upon free progesterone metabolism during advanced gestation in the guinea pig. J Steroid Biochem Mol Biol 1997; 62: 185-93.
173. Burger K, Fahrenholz F, Gimpl G. Non-genomic effects of progesterone on the signaling function of G protein-coupled receptors. FEBS Lett 1999; 464: 25-29.
174. Grazzini E, Guillon G, Mouillac B, Zingg HH. Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 1998; 392: 509-12.
175. 2+ homeostasis in human myometrial smooth muscle cells. Am J Physiol 1999; 276: C379-85.
176. Mukerji MS, Leathard HL, Huddart H. The effects of potassium channel blockers on progesterone-induced suppression of rat portal vein contractility. J Pharm Pharmacol 2000; 52: 983-90.